TUDCA skews microglia towards M2 phenotype through the G-protein coupled bile acid receptor GPBAR1/TGR5

被引:0
|
作者
Yanguas Casas, N. [1 ]
de la Barreda Manso, M. A. [1 ]
Nieto Sampedro, M. [1 ]
Romero Ramirez, L. [2 ]
机构
[1] CSIC, Inst Cajal, Neural Plast Grp, E-28002 Madrid, Spain
[2] Hosp Nacl Paraplej, Neural Plast Grp, Toledo, Spain
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T12-71A
引用
收藏
页码:E357 / E357
页数:1
相关论文
共 50 条
  • [1] TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells
    Yanguas-Casas, Natalia
    Asuncion Barreda-Manso, M.
    Nieto-Sampedro, Manuel
    Romero-Ramirez, Lorenzo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (08) : 2231 - 2245
  • [2] The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver
    Klindt, Caroline
    Reich, Maria
    Hellwig, Birte
    Stindt, Jan
    Rahnenfuehrer, Joerg
    Hengstler, Jan G.
    Koehrer, Karl
    Schoonjans, Kristina
    Haeussinger, Dieter
    Keitel, Verena
    CELLS, 2019, 8 (11)
  • [3] Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5)
    Chen, Tao
    Reich, Nicholas William
    Bell, Noah
    Finn, Patricia D.
    Rodriguez, David
    Kohler, Jill
    Kozuka, Kenji
    He, Limin
    Spencer, Andrew G.
    Charmot, Dominique
    Navre, Marc
    Carreras, Christopher W.
    Koo-McCoy, Samantha
    Tabora, Jocelyn
    Caldwell, Jeremy S.
    Jacobs, Jeffrey W.
    Lewis, Jason Gustaf
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) : 7589 - 7613
  • [4] G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
    Hoegenauer, Klemens
    Arista, Luca
    Schmiedeberg, Niko
    Werner, Gudrun
    Jaksche, Herbert
    Bouhelal, Rochdi
    Nguyen, Deborah G.
    Bhat, B. Ganesh
    Raad, Layla
    Rauld, Celine
    Carballido, Jose M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (24) : 10343 - 10354
  • [5] 2-Phenoxy-nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)
    Martin, Rainer E.
    Bissantz, Caterina
    Gavelle, Olivier
    Kuratli, Christoph
    Dehmlow, Henrietta
    Richter, Hans G. F.
    Sander, Ulrike Obst
    Erickson, Shawn D.
    Kim, Kyungjin
    Pietranico-Cole, Sherrie Lynn
    Alvarez-Sanchez, Ruben
    Ullmer, Christoph
    CHEMMEDCHEM, 2013, 8 (04) : 569 - 576
  • [6] Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects
    Han, Fanghui
    Ning, Mengmeng
    Cao, Hua
    Ye, Yangliang
    Feng, Ying
    Leng, Ying
    Shen, Jianhua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [7] The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway
    Guo, Cong
    Qi, Hui
    Yu, Yingjie
    Zhang, Qiqi
    Su, Jia
    Yu, Donna
    Huang, Wendong
    Chen, Wei-Dong
    Wang, Yan-Dong
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [8] Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system
    Poole, D. P.
    Godfrey, C.
    Cattaruzza, F.
    Cottrell, G. S.
    Kirkland, J. G.
    Pelayo, J. C.
    Bunnett, N. W.
    Corvera, C. U.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (07): : 814 - 825+e227
  • [9] Activation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits degradation of type II collagen and aggrecan in human chondrocytes
    Zhuo, Wenkun
    Li, Bingsheng
    Zhang, Dawei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 856
  • [10] Mogrol stimulates G-protein-coupled bile acid receptor 1 (GPBAR1/TGR5) and insulin secretion from pancreatic β-cells and alleviates hyperglycemia in mice
    Tanaka, Chisato
    Harada, Naoki
    Teraoka, Yoshiaki
    Urushizaki, Hiroki
    Shinmori, Yoh
    Onishi, Teruaki
    Yotsumoto, Yusuke
    Ito, Yuta
    Kitakaze, Tomoya
    Inui, Takashi
    Murata, Yuji
    Inui, Hiroshi
    Yamaji, Ryoichi
    SCIENTIFIC REPORTS, 2024, 14 (01)